Strategic Partnerships Antibody Solutions has a long-standing track record with over 500 clients including all of the top 10 global pharmaceutical companies, indicating strong credibility for channels that leverage preferred vendor relationships and sponsored collaboration opportunities.

Biologics Focus With capabilities spanning antigen design, monoclonal and polyclonal antibody generation and production, plus advanced analytical methods and engineering, target potential sales to biopharma programs in discovery and early development pipelines seeking end-to-end antibody solutions.

Global Service headquartered in Santa Clara but servicing clients worldwide, complemented by 24/7/365 online project management, suggesting scalability for international CRO engagements and continuous delivery models in multiple time zones.

SARS-CoV-2 Expertise Recent focus on antibodies to prevent spike protein cell entry and collaboration history with SARS-CoV-2 related research positions the firm for continued opportunities in infectious disease and therapeutic antibody programs, including rapid-response projects.

Growth Readiness Revenue visibility in the mid-market range with modest funding, indicating room for partner-driven expansion, larger project scopes, and value-added services such as conjugation, recombinant expression, and analytical method development to upsell to existing clients.